LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. operates as an investment holding company. The firm through its subsidiaries engages in manufacturing and sales of interventional treatment series occluders for defective congenital heart disease and the research and development of biological valve for heart disease. The company was founded on January 29, 2021 and is headquartered in Shanghai, China.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company